AtaiBeckley (ATAI) Operating Expenses (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Operating Expenses came in at $29.2 million in Q3 2025, up 28.9% year-on-year from $22.6 million in Q3 2024, and up 12.28% quarter-over-quarter from $26.0 million in Q2 2025.
AtaiBeckley (ATAI) Operating Expenses (2020 - 2026) Analysis & Trends
AtaiBeckley's Operating Expenses history runs 2 years deep, the most recent figure standing at $31.9 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 45.29% year-over-year to $31.9 million; the TTM figure through Mar 2026 stood at $53.8 million (changed N/A YoY), while the FY2025 annual figure was $648.2 million, up 529.28% from the prior year.
- Operating Expenses came in at $29.2 million for Q3 2025 at AtaiBeckley, up from $26.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $31.9 million in Q1 2026 to a low of $21.9 million in Q1 2025.
- The 5-year median for Operating Expenses is $32.0 million (2023), against an average of $32.0 million.
- Peak annual rise in Operating Expenses reached 952.69% in 2021, while the deepest fall reached 47.95% in 2021.
- AtaiBeckley's Operating Expenses stood at $45.4 million in 2021, then dropped by 17.18% to $37.6 million in 2022, then declined by 10.7% to $33.6 million in 2023, then decreased by 9.88% to $30.3 million in 2024, then retreated by 3.55% to $29.2 million in 2025.
- The last three Operating Expenses figures came in at $29.2 million (Q3 2025), $26.0 million (Q2 2025), and $21.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 31.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.86 Mn |
| Sep 30, 2025 | 29.19 Mn |
| Jun 30, 2025 | 25.99 Mn |
| Mar 31, 2025 | 21.93 Mn |
| Mar 31, 2025 | 21.93 Mn |
| Dec 31, 2024 | 30.26 Mn |
| Sep 30, 2024 | 22.64 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 24.09 Mn |
| Dec 31, 2023 | 33.58 Mn |
| Sep 30, 2023 | 26.92 Mn |
| Jun 30, 2023 | 32.03 Mn |
| Mar 31, 2023 | 33.25 Mn |
| Dec 31, 2022 | 37.60 Mn |
| Sep 30, 2022 | 38.45 Mn |
| Jun 30, 2022 | 35.53 Mn |
| Mar 31, 2022 | 33.44 Mn |
| Dec 31, 2021 | 45.41 Mn |
| Sep 30, 2021 | 33.63 Mn |
| Jun 30, 2021 | 61.32 Mn |